Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Imane Nafia"'
Autor:
Anne-Laure Blayo, Laurène Deshons, Alexia Dumont, Christel Franchet, Célia Halter, Ludovic Herbin, Gaël Hommet, Stanislas Mayer, Alban Bessede, Imane Nafia, Marjorie Sidhoum, Xavier Leroy, Stéphan Schann
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/d39d0b87f1fc43e1b9ad9bb03c60bc9a
Publikováno v:
Marine Drugs, Vol 20, Iss 1, p 12 (2021)
Fucoidan compounds may increase immune activity and are known to have cancer inhibitory effects in vitro and in vivo. In this study, we aimed to investigate the effect of fucoidan compounds on ex vivo human peripheral blood mononuclear cells (PBMCs),
Externí odkaz:
https://doaj.org/article/50cf3ae3c0f143e2964c98465fa716a2
Autor:
Imane Nafia, Maud Toulmonde, Doriane Bortolotto, Assia Chaibi, Dominique Bodet, Christophe Rey, Valerie Velasco, Claire B. Larmonier, Loïc Cerf, Julien Adam, François Le Loarer, Ariel Savina, Alban Bessede, Antoine Italiano
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Sarcomas are heterogeneous malignant mesenchymal neoplasms with limited sensitivity to immunotherapy. We recently demonstrated an increase in Kynurenine Pathway (KP) activity in the plasma of sarcoma patients treated with pembrolizumab. While the KP
Externí odkaz:
https://doaj.org/article/938b0aa849da43e2911a5a9d4a708446
Autor:
Maxime Assous, Laurence Had-Aissouni, Paolo Gubellini, Christophe Melon, Imane Nafia, Pascal Salin, Lydia Kerkerian-Le-Goff, Philippe Kachidian
Publikováno v:
Neurobiology of Disease, Vol 65, Iss , Pp 69-81 (2014)
Parkinson's disease (PD) is characterized by the progressive degeneration of substantia nigra (SN) dopamine neurons, involving a multifactorial cascade of pathogenic events. Here we explored the hypothesis that dysfunction of excitatory amino acid tr
Externí odkaz:
https://doaj.org/article/f9212e5a83dc4c359b8cf011d1914827
Autor:
Anne-Laure Blayo, Claire Jouffroy-Zeller, Nathalie Lenne, Imane Nafia, Patricia Zerr, Stéphan Schann, Xavier Leroy
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Alban Bessede, Jean Philippe Guegan, Imane Nafia, Assia Chaibi, Christophe Rey, Oren Ngouala, Florent Peyraud, Antoine Italiano
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Nathalie Chaput, Yohann Loriot, Antoine Italiano, Fabrice Andre, Jean-Charles Soria, Christophe Massard, Aurélien Marabelle, M. Khettab, Alban Bessede, David Planchard, Benjamin Besse, Luc Friboulet, Jean-Philippe Guegan, Imane Nafia, F. Le Loarer, François-Xavier Danlos, Caroline Even, Lambros Tselikas, Caroline Robert
Publikováno v:
Annals of Oncology. 32:1381-1390
Background Immune checkpoint blockers (ICBs) are now widely used in oncology. Most patients, however, do not derive benefit from these agents. Therefore, there is a crucial need to identify novel and reliable biomarkers of resistance to such treatmen
Autor:
Jean-Philippe Guegan, Florent Peyraud, Christophe Rey, Oren Ngouala, Ophélie Odin, Imane Nafia, Isabelle Soubeyran, Sylvestre Le Moulec, Alban Bessede, Antoine Italiano
Publikováno v:
Cancer Research. 83:4341-4341
Background: Immune checkpoint inhibitors (ICI) has revolutionized the management of patients with non-small cell lung cancer (NSCLC). However, most patients with advanced NSCLC patients displayed primary resistance to ICI. Indoleamine 2,3-dioxygenase
Autor:
Assia Chaibi, Coriolan Lebreton, Dominique Bodet, Jean-Philippe Guegan, Guillaume Babin, Antoine Italiano, Alban Bessede, Imane Nafia
Publikováno v:
Cancer Research. 83:4705-4705
Background: It’s now increasingly recognized that ovarian cancer (OC) ascites play a significant role in OC progression - behavior of tumor cells is influenced by the nature of their surrounding microenvironment. Thus, characterization of ascites c
Autor:
Imane Nafia, Assia Chaibi, Christophe Rey, Jean-Philippe Guegan, Alban Bessede, Coriolan Lebreton, Antoine Italiano
Publikováno v:
Cancer Research. 82:2527-2527
Background: Tumor microenvironment (TME) of epithelial ovarian cancer is unique among solid tumors as tumor cells create their "malignant ascites" TME. These ascites, acting as a complex mixture of soluble factors and cell components, are known to be